ZLDAF
Zelira Therapeutics Limited

29
Mkt Cap
$3.23M
Volume
14.00
52W High
$0.3547
52W Low
$0.20
PE Ratio
-1.32
ZLDAF Fundamentals
Price
$0.2716
Prev Close
$0.266
Open
$0.2716
50D MA
$0.233
Beta
0.11
Avg. Volume
93.82
EPS (Annual)
-$0.2046
P/B
-1.11
Loading...
Loading...
Zelira Therapeutics Ltd. is a bio-pharmaceutical company, which engages in the research, development and commercialisation of cannabinoid-based formulations for the treatment of a variety of medical conditions. It operates through the following geographical segments: Australia and USA. The company was founded by Harry Karelis, Mara Gordon, Jason Peterson, and Stewart Washer on February 18, 2003 and is headquartered in Perth, Australia.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Zelira Therapeutics Limited?
What is the 52-week high for Zelira Therapeutics Limited?
What is the 52-week low for Zelira Therapeutics Limited?
What is Zelira Therapeutics Limited stock price today?
What was Zelira Therapeutics Limited stock price yesterday?
What is the PE ratio of Zelira Therapeutics Limited?
What is the Price-to-Book ratio of Zelira Therapeutics Limited?
What is the 50-day moving average of Zelira Therapeutics Limited?

Latest ZLDAF News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.